Literature DB >> 29698893

Norditerpenoid alkaloids of Delphinium denudatum as cholinesterase inhibitors.

Hanif Ahmad1, Shujaat Ahmad2, Mumtaz Ali1, Abdul Latif1, Syed Adnan Ali Shah3, Humera Naz3, Najeeb Ur Rahman1, Farzana Shaheen4, Abdul Wadood5, Hidayat Ullah Khan6, Manzoor Ahmad7.   

Abstract

Three new norditerpenoids alkaloids, 1β-hydroxy,14β-acetyl condelphine (1), jadwarine-A (2), jadwarine-B (3) along with two known alkaloids isotalatizidine hydrate (4) and dihydropentagynine (5) were isolated from medicinal plant Delphinium denudatum. The structures of natural products 1-5 were established on the basis of HR-EIMS, 1H and 13C NMR (1D & 2D) spectroscopic data as well as by comparison from literature data. The structures of compound 1 and 4 were also confirmed by single crystal X-ray diffraction studies. In-vitro AChE and BChE enzyme inhibitory activities of compounds 1-5 and molecular docking studies were performed to investigate the possible molecular inhibitory mechanism of the isolated natural products. Compound 2, 4 and 5 showed competitive inhibitory effects by inhibiting AChE and BChE, respectively, while 1 and 3 showed non-competitive inhibition. This work is the first report that provides a supporting evidence about the use of constituents of Delphinium denudatum in cerebral dementia and Alzheimer diseases.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Delphinium denudatum; Enzyme inhibition activity; Norditerpenoid alkaloids; X-ray crystallography

Mesh:

Substances:

Year:  2018        PMID: 29698893     DOI: 10.1016/j.bioorg.2018.04.008

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  5 in total

1.  Plants with Anti-Addictive Potential.

Authors:  Eduardo Luis Konrath; Marcelo Dutra Arbo; Bruno Dutra Arbo; Mariana Appel Hort; Elaine Elisabetsky; Mirna Bainy Leal
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase.

Authors:  Rami J Obaid; Nafeesa Naeem; Ehsan Ullah Mughal; Munirah M Al-Rooqi; Amina Sadiq; Rabab S Jassas; Ziad Moussa; Saleh A Ahmed
Journal:  RSC Adv       Date:  2022-07-12       Impact factor: 4.036

3.  Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer's Disease Therapy.

Authors:  Lazhar Zribi; Irene Pachòn-Angona; Òscar M Bautista-Aguilera; Daniel Diez-Iriepa; José Marco-Contelles; Lhassane Ismaili; Isabel Iriepa; Fakher Chabchoub
Journal:  Molecules       Date:  2020-07-13       Impact factor: 4.411

Review 4.  An overview of the chemical constituents from the genus Delphinium reported in the last four decades.

Authors:  Tianpeng Yin; Le Cai; Zhongtao Ding
Journal:  RSC Adv       Date:  2020-04-03       Impact factor: 4.036

5.  In Vitro and In Silico Investigation of Diterpenoid Alkaloids Isolated from Delphinium chitralense.

Authors:  Shujaat Ahmad; Manzoor Ahmad; Mazen Almehmadi; Syed Adnan Ali Shah; Farman Ali Khan; Nasir Mehmood Khan; Asifullah Khan; Mustafa Halawi; Hanif Ahmad
Journal:  Molecules       Date:  2022-07-07       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.